iShares U.S. Pharmaceutic... (IHE)
66.39
0.36 (0.55%)
At close: Jan 15, 2025, 3:59 PM
66.46
0.11%
After-hours Jan 15, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 62.71 |
| Market Cap | 602.75M |
| AUM | - |
| NAV | - |
| EPS (ttm) | 2.76 |
| PE Ratio (ttm) | 24.05 |
| Shares Out | 9.08M |
| Inception Date | Invalid Date |
| Ask | 70 |
| Volume | 89.61K |
| Open | 66.49 |
| Previous Close | 66.03 |
| Day's Range | 66.04 - 66.64 |
| 52-Week Range | 62.31 - 72.94 |
| Holdings | - |
| Expense Ratio | undefined% |
About IHE
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Asset Class Equity
Ticker Symbol IHE
Inception Date May 5, 2006
Provider Blackrock
Website Fund Home Page
Top Holdings 61.09% of assets
| Company | Portfolio |
|---|---|
LLY Eli Lilly And Compan... | 23.55% |
JNJ Johnson & Johnson | 23.16% |
PFE Pfizer Inc. | 4.99% |
MRK Merck & Co., Inc. | 4.76% |
ITCI Intra-cellular Thera... | 4.63% |
Dividends Dividend Yield 1.27%
| Ex-Dividend | Payment Date | Amount |
|---|---|---|
| Dec 17, 2024 | Dec 20, 2024 | $0.21 |
| Sep 25, 2024 | Sep 30, 2024 | $0.36 |
| Jun 11, 2024 | Jun 17, 2024 | $0.29 |
| Mar 21, 2024 | Mar 27, 2024 | $0.28 |
| Dec 20, 2023 | Dec 27, 2023 | $0.13 |
